Susan Zeveloff, MD
Internal Medicine · Bergenfield, NJNPI 1821108937
Payments from drug & device makers
Across 71 payments — averaging $19.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$172
- Ardelyx, Inc.$149
- Baxter Healthcare$114
- Johnson & Johnson$107
- Amgen$88
- AstraZeneca$86
- plus $663 from 20 others
What the payments were for
- Food & beverage$1,32196%
- Gifts$584%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 12 | $172 |
| Ardelyx, Inc. | 1 | $149 |
| Baxter Healthcare | 1 | $114 |
| Johnson & Johnson | 7 | $107 |
| Amgen | 4 | $88 |
| AstraZeneca(2 entities) | 6 | $86 |
| Sanofi Pasteur Inc. | 3 | $83 |
| Bayer | 4 | $68 |
| Novartis | 4 | $56 |
| EMD Serono, Inc. | 4 | $55 |
| Regeneron Healthcare Solutions, Inc. | 4 | $55 |
| Vantive US Healthcare LLC | 1 | $54 |
| Incyte Corporation | 3 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Sun Pharmaceutical Industries Inc. | 2 | $28 |
| Seagen Inc. | 2 | $27 |
| Novocure Inc. | 1 | $22 |
| Sobi, Inc | 1 | $15 |
| Bristol Myers Squibb | 1 | $15 |
| Beigene USA, Inc. | 1 | $14 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| TG Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XPHOZAH 30 MG$149
How this compares
$1,378 in reported general payments places this provider in the 70th percentile of 4,032 internal medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 25 | $22,964 |
| JardianceEmpagliflozin | 13 | $7,187 |
| Atorvastatin Calcium | 263 | $2,400 |
| Rosuvastatin Calcium | 109 | $1,889 |
| Amlodipine Besylate | 211 | $1,877 |
| Levothyroxine Sodium | 146 | $1,864 |
| Metoprolol Succinate | 99 | $1,524 |
| Valsartan | 26 | $1,461 |
| Candesartan Cilexetil | 15 | $1,051 |
| Ezetimibe | 20 | $1,023 |
| Losartan Potassium | 109 | $891 |
| Ventolin HfaAlbuterol Sulfate | 14 | $787 |
| Pravastatin Sodium | 43 | $777 |
| Lisinopril | 48 | $776 |
| Esomeprazole Magnesium | 14 | $615 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Bergenfield
- Sanjiv SharmaToms River$33.9M
- Jeffrey CarsonNew Brunswick$13.8M
- Samer HaddadHamilton$6.8M
- Magdy ShenoudaWall$3.7M
- Samar HameedLivingston$3.6M
- Jane RohlfTrenton$2.7M
- Mohammed NisarEdison$2.6M
- Michael CasserNew Milford$2.2M
- Sumitha ReddyHamilton$2M
- Helio PedroNewark$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.